Publications

Title

Author

Year

Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia.

Enwere, G; Biney, E; Cheung, YB; ZAMAN, SM A; Okoko, B; Oluwalana, C; Vaughan, A; GREENWOOD, B; Adegbola, R; Cutts, FT;

2006

The Pediatric infectious disease journal, (2006).25 8 10.1097/01.inf.0000226839.30925.a5.

Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine.

GORAK-STOLINSKA, P; Weir, RE; FLOYD, S; Lalor, MK; Stenson, S; BRANSON, K; BLITZ, R; Luke, S; Nazareth, B; Ben-Smith, A; FINE, PE M; DOCKRELL, HM;

2006

Vaccine, (2006).24 29-30 10.1016/j.vaccine.2006.04.037.

Operational challenges in large clinical trials: examples and lessons learned from the gambia pneumococcal vaccine trial.

Cutts, FT; Enwere, G; ZAMAN, SM A; Yallop, FG;

2006

PLoS clinical trials, (2006).1 3 10.1371/journal.pctr.0010016.

Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.

Adegbola, RA; Hill, PC; Secka, O; IKUMAPAYI, UN; Lahai, G; GREENWOOD, BM; Corrah, T;

2006

Tropical medicine & international health, (2006).11 7 10.1111/j.1365-3156.2006.01652.x.

Pneumococcal vaccination in developing countries.

Levine, OS; O'Brien, KL; Knoll, M; Adegbola, RA; Black, S; Cherian, T; Dagan, R; Goldblatt, D; Grange, A; GREENWOOD, B; Hennessy, T; Klugman, KP; Madhi, SA; MULHOLLAND, K; Nohynek, H; Santosham, M; Saha, SK; SCOTT, JA; Sow, S; Whitney, CG; Cutts, F;

2006

Lancet, (2006).367 9526 10.1016/S0140-6736(06)68703-5.

Validation of influenza and pneumococcal vaccine status in adults based on self-report.

MANGTANI, P; Shah, A; Roberts, JA;

2006

Epidemiology and infection, (2006).135 1 10.1017/S0950268806006479.

A vision of a world without polio: the OPV cessation strategy.

HEYMANN, DL; Sutter, RW; Aylward, RB;

2006

Biologicals, (2006).34 2 10.1016/j.biologicals.2006.03.005.

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.

Enosse, S; Dobaño, C; Quelhas, D; Aponte, JJ; Lievens, M; Leach, A; Sacarlal, J; GREENWOOD, B; Milman, J; Dubovsky, F; Cohen, J; Thompson, R; Ballou, WR; Alonso, PL; CONWAY, DJ; SUTHERLAND, CJ;

2006

PLoS clinical trials, (2006).1 1 10.1371/journal.pctr.0010005.

Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.

Ndiritu, M; Cowgill, KD; Ismail, A; Chiphatsi, S; Kamau, T; Fegan, G; Feikin, DR; Newton, CR J C; SCOTT, JA G;

2006

BMC public health, (2006).6 1 10.1186/1471-2458-6-132.

From genomics to surveillance, prevention and control: new challenges for the African meningitis belt.

Alonso, J-M; Bertherat, E; Perea, W; Borrow, R; Chanteau, S; Cohet, C; Dodet, B; GREENWOOD, B; LaForce, FM; Rouzic, EM-L; Teyssou, R; Ouedraogo-Traoré, R; Sow, I;

2006

Vaccine, (2006).24 20 10.1016/j.vaccine.2006.03.037.